vs
Anika Therapeutics, Inc.（ANIK）与Apyx Medical Corp（APYX）财务数据对比。点击上方公司名可切换其他公司
Anika Therapeutics, Inc.的季度营收约是Apyx Medical Corp的1.6倍（$30.6M vs $19.2M）。Anika Therapeutics, Inc.净利率更高（1.0% vs -6.8%，领先7.7%）。Apyx Medical Corp同比增速更快（34.7% vs 0.0%）。Anika Therapeutics, Inc.自由现金流更多（$4.0M vs $-2.8M）。过去两年Apyx Medical Corp的营收复合增速更高（36.8% vs 2.7%）
Apyx Medical前身是博维医疗，是美国的医疗器械制造商，专注生产电外科产品与能源技术相关医疗设备，公司总部位于佛罗里达州克利尔沃特，在保加利亚设有生产工厂。
ANIK vs APYX — 直观对比
营收规模更大
ANIK
是对方的1.6倍
$19.2M
营收增速更快
APYX
高出34.7%
0.0%
净利率更高
ANIK
高出7.7%
-6.8%
自由现金流更多
ANIK
多$6.8M
$-2.8M
两年增速更快
APYX
近两年复合增速
2.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $30.6M | $19.2M |
| 净利润 | $292.0K | $-1.3M |
| 毛利率 | 62.6% | 62.6% |
| 营业利润率 | 2.1% | 0.1% |
| 净利率 | 1.0% | -6.8% |
| 营收同比 | 0.0% | 34.7% |
| 净利润同比 | 101.3% | 71.9% |
| 每股收益（稀释后） | $0.02 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANIKAPYX
| Q4 25 | $30.6M | $19.2M | ||
| Q3 25 | $27.8M | $12.9M | ||
| Q2 25 | $28.2M | $11.4M | ||
| Q1 25 | $26.2M | $9.4M | ||
| Q4 24 | $30.6M | $14.2M | ||
| Q3 24 | $29.6M | $11.5M | ||
| Q2 24 | $30.7M | $12.1M | ||
| Q1 24 | $29.0M | $10.2M |
净利润ANIKAPYX
| Q4 25 | $292.0K | $-1.3M | ||
| Q3 25 | $-2.3M | $-2.0M | ||
| Q2 25 | $-4.0M | $-3.8M | ||
| Q1 25 | $-4.9M | $-4.2M | ||
| Q4 24 | $-21.9M | $-4.6M | ||
| Q3 24 | $-29.9M | $-4.7M | ||
| Q2 24 | $-88.0K | $-6.6M | ||
| Q1 24 | $-4.5M | $-7.6M |
毛利率ANIKAPYX
| Q4 25 | 62.6% | 62.6% | ||
| Q3 25 | 56.0% | 64.4% | ||
| Q2 25 | 50.9% | 62.3% | ||
| Q1 25 | 56.1% | 60.1% | ||
| Q4 24 | 56.0% | 63.0% | ||
| Q3 24 | 65.7% | 60.5% | ||
| Q2 24 | 66.7% | 61.7% | ||
| Q1 24 | 65.4% | 58.1% |
营业利润率ANIKAPYX
| Q4 25 | 2.1% | 0.1% | ||
| Q3 25 | -11.6% | -6.5% | ||
| Q2 25 | -14.8% | -22.6% | ||
| Q1 25 | -16.4% | -32.4% | ||
| Q4 24 | -2.3% | -21.4% | ||
| Q3 24 | -0.3% | -31.6% | ||
| Q2 24 | -5.9% | -45.7% | ||
| Q1 24 | -8.6% | -64.6% |
净利率ANIKAPYX
| Q4 25 | 1.0% | -6.8% | ||
| Q3 25 | -8.4% | -15.4% | ||
| Q2 25 | -14.1% | -33.2% | ||
| Q1 25 | -18.6% | -44.0% | ||
| Q4 24 | -71.4% | -32.5% | ||
| Q3 24 | -101.2% | -40.9% | ||
| Q2 24 | -0.3% | -54.0% | ||
| Q1 24 | -15.6% | -74.0% |
每股收益（稀释后）ANIKAPYX
| Q4 25 | $0.02 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.28 | — | ||
| Q1 25 | $-0.34 | — | ||
| Q4 24 | $-1.49 | — | ||
| Q3 24 | $-2.03 | — | ||
| Q2 24 | $0.00 | $-0.19 | ||
| Q1 24 | $-0.31 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $81.2M | $31.7M |
| 总债务越低越好 | — | $37.5M |
| 股东权益账面价值 | $143.5M | $14.5M |
| 总资产 | $190.3M | $66.8M |
| 负债/权益比越低杠杆越低 | — | 2.58× |
8季度趋势，按日历期对齐
现金及短期投资ANIKAPYX
| Q4 25 | $81.2M | $31.7M | ||
| Q3 25 | $80.2M | $25.1M | ||
| Q2 25 | $77.1M | $29.3M | ||
| Q1 25 | $75.4M | $31.0M | ||
| Q4 24 | $79.2M | $31.7M | ||
| Q3 24 | $90.7M | $28.0M | ||
| Q2 24 | $96.6M | $32.7M | ||
| Q1 24 | $100.7M | $37.3M |
总债务ANIKAPYX
| Q4 25 | — | $37.5M | ||
| Q3 25 | — | $37.5M | ||
| Q2 25 | — | $37.5M | ||
| Q1 25 | — | $37.5M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | — | $37.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ANIKAPYX
| Q4 25 | $143.5M | $14.5M | ||
| Q3 25 | $146.8M | $5.8M | ||
| Q2 25 | $147.7M | $7.3M | ||
| Q1 25 | $148.4M | $10.5M | ||
| Q4 24 | $154.0M | $14.2M | ||
| Q3 24 | $179.9M | $11.0M | ||
| Q2 24 | $210.3M | $14.7M | ||
| Q1 24 | $208.5M | $20.3M |
总资产ANIKAPYX
| Q4 25 | $190.3M | $66.8M | ||
| Q3 25 | $189.4M | $57.4M | ||
| Q2 25 | $187.7M | $58.2M | ||
| Q1 25 | $190.6M | $60.2M | ||
| Q4 24 | $202.7M | $64.8M | ||
| Q3 24 | $231.4M | $60.7M | ||
| Q2 24 | $262.7M | $65.4M | ||
| Q1 24 | $263.7M | $70.7M |
负债/权益比ANIKAPYX
| Q4 25 | — | 2.58× | ||
| Q3 25 | — | 6.41× | ||
| Q2 25 | — | 5.17× | ||
| Q1 25 | — | 3.57× | ||
| Q4 24 | — | 2.64× | ||
| Q3 24 | — | 3.40× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.6M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $4.0M | $-2.8M |
| 自由现金流率自由现金流/营收 | 13.0% | -14.6% |
| 资本支出强度资本支出/营收 | 2.1% | 1.4% |
| 现金转化率经营现金流/净利润 | 15.88× | — |
| 过去12个月自由现金流最近4个季度 | $4.4M | $-9.1M |
8季度趋势，按日历期对齐
经营现金流ANIKAPYX
| Q4 25 | $4.6M | $-2.5M | ||
| Q3 25 | $6.9M | $-3.5M | ||
| Q2 25 | $-189.0K | $-1.2M | ||
| Q1 25 | $-130.0K | $-702.0K | ||
| Q4 24 | $1.6M | $-2.9M | ||
| Q3 24 | $5.0M | $-4.4M | ||
| Q2 24 | $-1.1M | $-4.3M | ||
| Q1 24 | $-126.0K | $-6.3M |
自由现金流ANIKAPYX
| Q4 25 | $4.0M | $-2.8M | ||
| Q3 25 | $5.0M | $-4.1M | ||
| Q2 25 | $-1.7M | $-1.5M | ||
| Q1 25 | $-3.0M | $-757.0K | ||
| Q4 24 | $275.0K | $-3.2M | ||
| Q3 24 | $3.8M | $-4.6M | ||
| Q2 24 | $-4.5M | $-4.6M | ||
| Q1 24 | $-1.9M | $-6.4M |
自由现金流率ANIKAPYX
| Q4 25 | 13.0% | -14.6% | ||
| Q3 25 | 17.9% | -31.5% | ||
| Q2 25 | -5.9% | -13.2% | ||
| Q1 25 | -11.3% | -8.0% | ||
| Q4 24 | 0.9% | -22.4% | ||
| Q3 24 | 12.9% | -40.0% | ||
| Q2 24 | -14.6% | -38.0% | ||
| Q1 24 | -6.7% | -62.2% |
资本支出强度ANIKAPYX
| Q4 25 | 2.1% | 1.4% | ||
| Q3 25 | 6.8% | 4.0% | ||
| Q2 25 | 5.2% | 2.3% | ||
| Q1 25 | 10.8% | 0.6% | ||
| Q4 24 | 4.3% | 1.7% | ||
| Q3 24 | 4.1% | 1.3% | ||
| Q2 24 | 11.1% | 2.4% | ||
| Q1 24 | 6.2% | 0.3% |
现金转化率ANIKAPYX
| Q4 25 | 15.88× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANIK
| OEM Channel | $17.3M | 57% |
| Commercial Channel | $13.3M | 43% |
APYX
暂无分部数据
